Abstract:The biological application of thiosemicarbazide transition metal complexes is the focus of current research. In order to better understand the interaction mechanism between thiosemicarbazide aryl ruthenium complexes and has, two thiosemicarbazide aryl ruthenium( II) complexes were synthesized. The fluorescence quenching mechanism of two thiosemicarbazide aryl ruthenium complexes with human albumin was studied by time-resolved fluorescence spectroscopy and steady-state fluorescence spectroscopy. Fluorescence spectroscopy results indicate that these two thiosemicarbazide aryl ruthenium complexes could quench the endogenous fluorescence of has, and the fluorescence quenching effect of HSA was linear with the concentration of the complex. It was found that the fluorescence quenching efficiency of complex 2 was stronger. The quenching and binding constants of the two complexes interacting with HSA decrease with the increase in temperature. Therefore, the interaction process between the complexes and HSA was a static quenching process, and the fluorescence quenching ability of complex 2 was stronger. Through the analysis of thermodynamic parameters, the main binding forces between the two complexes and HSA are hydrogen bond, and van der Waals force, and the binding process between the two complexes and HSA was spontaneous. Finally, the infrared absorption and circular dichroism spectra show that the two thiosemicarbazide aryl ruthenium complexes have different effects on the secondary conformation and microenvironment of HSA. The infrared absorption spectra show that combining the two complexes with HSA causes the rearrangement of the secondary structure of HSA, Circular dichroism spectra showed that the addition of these two complexes reduced the secondary structure stability of HSA. The above studies show that exploring the effect of thiosemicarbazide aryl ruthenium complex on the structure and function of human serum albumin can reveal its possible mechanism of action with HSA after entering the body as an antitumor drug. Therefore, it provides a theoretical reference for researching and developing aryl ruthenium complex anti-tumor drugs with thiosemicarbazide as the ligand.

Arene Control over Thiolate to Sulfinate Oxidation in Albumin by Organometallic Ruthenium Anticancer Complexes

Organometallic Ruthenium Anticancer Complexes Inhibit Human Glutathione-S-transferase Π.

In vitro interaction investigation between three Ru(II) arene complexes and human serum albumin: structural influences

Ruthenium (II) Complexes Binding to Human Serum Albumin and Inducing Apoptosis of Tumor Cells

Comparative Investigation of Interactions Between Two Ruthenium(ii) Arene PTA Type Complexes with Curcuminoid Ligands and Human Serum Albumin

Reactions of an organoruthenium anticancer complex with 2-mercaptobenzanilide--a model for the active-site cysteine of protein tyrosine phosphatase 1B.

Ruthenium (II) Complexes Interact with Human Serum Albumin and Induce Apoptosis of Tumor Cells

Organometallic Ruthenium Anticancer Complexes Inhibit Human Peroxiredoxin I Activity by Binding to and Inducing Oxidation of Its Catalytic Cysteine Residue.

Synthesis and in vitro anticancer activities of chiral ruthenium complexes and interaction of the complex with bovine serum albumin

Ruthenation of duplex and single-stranded d(CGGCCG) by organometallic anticancer complexes.

Chiral Ruthenium Complexes Induce Apoptosis of Tumor Cell and Interact with Bovine Serum Albumin

Fortuitous synthesis of unsaturated half-sandwich Ruthenium(II) complexes via solvent-involved rearrangement and their biological evaluation

Study on the Interaction Mechanism Between Thiosemicarbazide Aryl Ruthenium Complexes and Human Serum Albumin

Protein binding by dinuclear polypyridyl ruthenium(II) complexes and the effect of cucurbit[10]uril encapsulation.

Antitumor Effect of Organometallic Half-Sandwich Ru(II)-Arene Complexes Bearing a Glutathione <i>S</i>-Transferase Inhibitor

Ruthenium Arene Complex Induces Cell Cycle Arrest and Apoptosis Through Activation of P53-mediated Signaling Pathways

Synthesis, Crystal and Electronic Structure, Anticancer Activity of Ruthenium(Ii) Arene Complexes with Thiosemicarbazones

Ruthenium Complexes of Phenylbenzothiazole‐Quinoline based Ligands for Selective α‐Olefination of Methylazaarenes

Binding of Organometallic Ruthenium Anticancer Complexes to DNA: Thermodynamic Base and Sequence Selectivity.

Penetrative Dna Intercalation and G-Base Selectivity of an Organometallic Tetrahydroanthracene Ru-Ii Anticancer Complex

Catechol Oxidase, Phosphatase-Like Activity, Dna/Bsa Binding Studies of Ru-Ii Complexes of S-Allyldithiocarbazate: Synthesis and Spectral Studies